Moreover, although previous studies reported that MGMT methylation was associated with a better prognosis and better response to chemotherapy in GBM patients [23], lower TAF12 expression was observed in samples with MGMT methylation in the CGGA (Supplementary Figure S1B). The gene discussed is TAF12; the disease is glioblastoma.